Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment ...Middle East

GAITHERSBURG, Md. and SUZHOU, China, May 30, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the launch of a Phase I clinical trial of the...

Hence then, the article about sirnaomics launches phase i clinical trial of rnai therapeutic stp705 in adults undergoing abdominoplasty for medical cosmetology treatment was published today ( Monday 30/05/2022 - 11:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment )

Also on site :

• Chainlink and Multinational Banking Consortia Launch Project Pangea To Develop T+0 Settlement Framework for International FX Markets
• The 1999 Movie That Changed Horror Forever Is Returning to Theaters — and It Has a Premiere Date
• This New Ultra-Luxury Hotel Lets Travelers Stay Inside One of the World's Oldest UNESCO Biosphere Reserves